Stay updated on Aldesleukin and Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Aldesleukin and Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Aldesleukin and Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The web page now includes a service alert about planned maintenance starting July 25th, which will affect service availability for over 24 hours. Additionally, the version has been updated from v2.16.4 to v2.16.5.
    Difference
    2%
    Check dated 2025-07-12T02:31:09.000Z thumbnail image
  2. Check
    27 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.
    Difference
    0.7%
    Check dated 2025-06-20T18:16:05.000Z thumbnail image
  3. Check
    34 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.2 to version 2.16.3.
    Difference
    0.1%
    Check dated 2025-06-13T15:57:34.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.1%
    Check dated 2025-06-06T09:39:38.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    The web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.
    Difference
    1.0%
    Check dated 2025-05-30T04:40:36.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.0, replacing the previous version 2.15.2.
    Difference
    0.2%
    Check dated 2025-05-23T01:54:19.000Z thumbnail image

Stay in the know with updates to Aldesleukin and Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Aldesleukin and Pembrolizumab in Melanoma Clinical Trial page.